UBS Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Sell
16,300
-6,200
-28% -$1.34M ﹤0.01% 4450
2025
Q4
$4.62M Sell
22,500
-3,800
-14% -$715K ﹤0.01% 4106
2025
Q3
$4.13M Buy
26,300
+24,400
+1,284% +$3.77M ﹤0.01% 4242
2025
Q2
$319K Sell
1,900
-100
-5% -$14.8K ﹤0.01% 6395
2025
Q1
$276K Sell
2,000
-30,000
-94% -$3.82M ﹤0.01% 6317
2024
Q4
$3.78M Hold
32,000
﹤0.01% 4122
2024
Q3
$3.54M Hold
32,000
﹤0.01% 3424
2024
Q2
$3.15M Buy
32,000
+2,000
+7% +$204K ﹤0.01% 3303
2024
Q1
$3.36M Buy
+30,000
New +$3.24M ﹤0.01% 3395
2022
Q1
Sell
-80,000
Closed -$4.12M 10291
2021
Q4
$4.12M Hold
80,000
﹤0.01% 3036
2021
Q3
$3.96M Hold
80,000
﹤0.01% 2919
2021
Q2
$4.57M Buy
80,000
+40,000
+100% +$2.34M ﹤0.01% 2773
2021
Q1
$2.43M Sell
40,000
-25,000
-38% -$1.38M ﹤0.01% 3365
2020
Q4
$3.48M Hold
65,000
﹤0.01% 2836
2020
Q3
$3.05M Hold
65,000
﹤0.01% 2660
2020
Q2
$3.39M Buy
65,000
+40,000
+160% +$2.06M ﹤0.01% 2389
2020
Q1
$1.2M Hold
25,000
﹤0.01% 3203
2019
Q4
$1.26M Hold
25,000
﹤0.01% 3985
2019
Q3
$1.18M Hold
25,000
﹤0.01% 3818
2019
Q2
$1.18M Buy
+25,000
New +$1.15M ﹤0.01% 3618
2015
Q1
Sell
-300
Closed -$24K 8848
2014
Q4
$24K Buy
+300
New +$23.7K ﹤0.01% 7373

Other funds holding CAH

UBS Group's CAH Position: Q1 2026 in Review

UBS Group reduced its Cardinal Health (CAH) stake by 13% in Q1 2026, selling an estimated $27.8M and leaving 839,569 shares worth $177M. The position accounts for 0.03% of the portfolio, ranked #671.

UBS Group first reported a position in CAH in Q4 2014 and has held it in 46 quarters since. The position peaked at $199M in Q4 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • UBS Group held 839,569 shares of Cardinal Health worth $177M as of Q1 2026.
  • UBS Group sold 129,278 Cardinal Health shares in Q1 2026, an estimated $27.8M.
  • Cardinal Health made up 0.03% of UBS Group's portfolio in Q1 2026, its #671 holding.
  • UBS Group first reported a position in Cardinal Health in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Cardinal Health position peaked at $199M in Q4 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.